INmune Bio
INMB
trading on NASDAQ
since 2019
$11.38
(Δ 49.25%)
+$3.63 since open
INmune Bio is a biotechnology company focused on developing innovative immune-modulating therapies to address chronic diseases and cancer.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.40 | $7.64 | $6.11 | $149.16M | 5.56M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.43 | n/a | 5120.13 | -19810.00% | -19478.00% | 0% |